WO2011017903A1 - Dispositif de traitement de région ombilicale - Google Patents

Dispositif de traitement de région ombilicale Download PDF

Info

Publication number
WO2011017903A1
WO2011017903A1 PCT/CN2010/001090 CN2010001090W WO2011017903A1 WO 2011017903 A1 WO2011017903 A1 WO 2011017903A1 CN 2010001090 W CN2010001090 W CN 2010001090W WO 2011017903 A1 WO2011017903 A1 WO 2011017903A1
Authority
WO
WIPO (PCT)
Prior art keywords
information
treatment
box
treatment box
umbilical
Prior art date
Application number
PCT/CN2010/001090
Other languages
English (en)
Chinese (zh)
Inventor
杨孟君
Original Assignee
Yang Mengjun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yang Mengjun filed Critical Yang Mengjun
Publication of WO2011017903A1 publication Critical patent/WO2011017903A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood

Definitions

  • the invention belongs to a medical device, and particularly relates to a treatment device for a human umbilicus.
  • Umbilical therapy is a commonly used medical technique.
  • Existing umbilical therapy techniques or patents are made into traditional dosage forms such as paste, scatter, pills, cream, etc., applied to the umbilicus, or applied to the umbilicus to apply certain physical stimuli, such as moxibustion, needles. Sting, hot ironing, cupping, etc., to treat the disease.
  • the transdermal patch invented in recent years is also used as a navel treatment.
  • These patents or techniques have the common feature of either absorbing the drug through the umbilical navel skin and allowing the drug to enter the body; or applying some physical stimulation to the navel of the umbilicus to modulate the body through skin acupoint stimulation.
  • the defects of these navel therapy techniques are: Whether the drug is applied directly to the navel or directly exerts physical stimulation on the navel, it has bad stimulation or injury to the navel skin; the clinical curative effect is not ideal, and can not be used as the main means of treating diseases; Sticking to the navel, the drug is absorbed into the human body through the navel, and the toxic side effects of the drug are still unavoidable.
  • the object of the present invention is to propose a new and innovative umbilical treatment device that does not directly contact the human body in view of the deficiencies of the current navel therapy technology.
  • An umbilical treatment device comprising a treatment box 4 and a fixture 5 for use with the treatment box 4, and a venting hole 6 on the treatment box 4, wherein the treatment box 4 is a carrier, To achieve a new mode of administration of bioinformation.
  • the treatment box 4 comprises a lid 2 and a box 3, and the box 3 is provided with an information packing block or a packing bag 1.
  • the information filler block or the information filler package 1 is made of a non-attenuating information material, and the non-attenuating information material refers to a drug having pharmacological activity and treating diseases for a new production period of less than one year.
  • the information filler block or the information in the information filler package 1 includes a physiological function for regulating human or animal diseases for the purpose of treating and/or preventing human or animal diseases,
  • the information filling block 1 is pressed by using a relevant mold, and after the medicine is directly loaded into the mold, it is pressed into a shape by a press; or the adhesive is added to the medicine. after mixing into a mold after press molding with a press fingers; the filler information packet 1 with a pharmaceutical excipient added, mixed sufficiently charged 50n m - packet object made of microporous material aperture 20 Um air bags.
  • the umbilical treatment device of the present invention in a ratio of 90-99% of the total weight of the drug relative to the information filler block, and 1-10% of the total weight of the adhesive relative to the information filler block, at normal temperature and pressure
  • the 10-100 ton press to make the block packing material, ie, the information packing block 1; or take the medicine, add the auxiliary material, mix well at normal temperature and pressure or granulate and dry, and dispense with the filling machine.
  • the information packing package 1 Into the 50nm-20 pore size microporous material venting bag, that is, the information packing package 1.
  • the vent hole 7 is disposed on the lid 2 or at the bottom of the casing 3.
  • the venting hole 7 has a diameter of 0. 01-0. 5cm.
  • the fixture 5 includes a therapeutic box 4 Or a rope, belt, bag, rack, paste or tape that is fixed to the umbilicus of the human body.
  • the lid 2 is connected to the casing 3 by screwing or the socket is clamped or the adhesive is adhered.
  • the clinical treatment effect is significant, can achieve or exceed the effectiveness of drug treatment.
  • the umbilical unit can be reused many times within 3 years, reducing the waste of drugs in conventional treatment, saving medical resources, and reducing environmental pollution in the pharmaceutical industry, which is conducive to environmental protection. 5, easy to use, convenient for family self-healing treatment.
  • Figure 1 is a schematic view of the treatment box of the present invention (the lid is open);
  • Fig. 2 is a schematic view showing the treatment box and the fixture of the present invention (the lid is closed).
  • an umbilical treatment device consists of a treatment box 4 and a fixture 5 for use with the treatment box 4.
  • the treatment box 4 is composed of a lid 2 and a box body 3, in which an information packing block or packing bag 1 is mounted, and an information packing block or packing bag 1 is made of a non-attenuating information material, the non-attenuating information
  • the material refers to a pharmacologically active drug that has been produced for no more than one year.
  • the fixture 5 includes a cord, a belt, a bag, a shelf, a sticker or a tape that can suspend or secure the treatment cartridge 4 to the umbilicus of the human body.
  • the fixture 5 is used to hang the treatment box 4 or directly attached to the umbilicus of the human body.
  • the fixture 5 can be integrated with the treatment box 4 or can be placed separately from the treatment box 4, but used in conjunction with each other.
  • the casing 3 is provided with a perforation hole 7.
  • the fixture 5 is a belt which is worn on the perforation hole 7 and then tethered to the human body.
  • a venting hole 6 is disposed on the treatment box 4. The best way is to vent the venting hole 6 on the lid 2 and the bottom of the box body 3 to ensure that the inside and outside of the treatment box 4 are ventilated, and the medicine information in the box 4 is treated. Superconducting emission.
  • the vent hole 6 has a pore diameter of 0.01 to 0.5 cm.
  • the treatment box 4 is made of a plastic, ceramic or metal-formable material, and the shape of the treatment box 4 can be various shapes. After the information packing block or packing bag 1 is placed in the treatment box 3, the treatment box cover 2 is closed. The treatment box cover 2 can be connected to the treatment box body 3 by screwing or the socket is fastened or the adhesive is adhered.
  • the drug information filler block or filler package 1 used is made of a non-attenuating information material, i.e., a drug having pharmacological activity.
  • the medicaments are for the treatment and prevention of human and animal diseases, for the purpose of regulating the physiological functions of humans or animals or for the treatment of a single compound, biological product and composition of the human or animal for conception or contraception and beauty.
  • the drugs are approved for use by the national government drug administration, and are in compliance with national pharmacopoeia standards or national and other standards.
  • the information filling block 1 is pressed by using a related mold, and the medicine is directly loaded into a mold and then pressed into a shaped object by a press, or the medicine is added to a certain proportion of a binder, such as sodium carboxymethyl cellulose, and then mixed. After entering the mold, it is pressed into a tangible block by a press.
  • the information filler package 1 is a small bag object prepared by adding a suitable excipient with a drug and mixing it into a gas-permeable bag of a microporous material having a pore diameter of 50 nm to 20 ⁇ m.
  • the production process of the invention is: 1 according to the structural requirements of the present invention, the conventional processing process of the treatment box 4, the fixture 5; 2 take the attenuation-free information material 90-99% by weight, the binder 1-10% by weight, at normal temperature and pressure
  • the mold is filled into a block with a 10-100 ton press, that is, the information packing block 1; or the non-attenuating information material is added, an appropriate amount of the auxiliary material is added, and the mixture is sufficiently mixed under normal temperature and normal pressure, or granulated and dried
  • the dispensing machine is filled into a 50nm-20um pore size microporous material venting bag to form an information packing package 1; the non-attenuating information material is a pharmacologically active drug newly produced without leaving the factory for more than one year, that is, for treatment and prevention.
  • Human and animal diseases a single compound, biological product, and composition that purposely regulates human or animal physiology or acts on the human or animal for conception or contraception and beauty, and meets appropriate national standards.
  • 3 Put the information packing block or packing bag 1 into the treatment box 4, cover The treatment box cover 2 is fixed and fixed firmly; 4 the fixture 5 is mounted on the treatment box 4; 5 The treatment box 4 is placed in a sealed box or bag which is completely airtight and sealed and stored dry.
  • the method of use of the invention is: opening a sealed box or sealed bag which is completely airtight, taking out the treatment box 4, pulling apart the suspension or the fixture 5, placing the treatment box 4 on the umbilicus of the human body, and making the treatment box 4 have the venting hole 6
  • the bottom or the lid 2 with the venting opening 6 faces the umbilicus skin, and is suspended or fixed in the umbilicus of the human body during the clinically prescribed treatment time.
  • the treatment box 4 is removed and placed completely Sealed in a gas-tight sealed box or sealed bag.
  • the use of the present invention is to treat and prevent human and animal diseases, and to be used in human health and beauty.
  • the "%” described in the following examples is “% by weight”.
  • the treatment box 4 is injection molded with an injection mold and ABS plastic material. Designed to be oblate, 10 cm in diameter, 1.5 cm in height, 1.2 cm in height, and a plurality of vent holes 6 having a diameter of 0.1 cm (the venting holes 6 are provided at the bottom of the casing 3 of the treatment box 4) on the treatment box 4, designed
  • the suspension belt is provided with a hole 7.
  • the packing block 1 has a diameter of 9.5 cm, a center height of 1.3 cm, and a peripheral height of 1.0 cm.
  • the information packing block 1 is placed in the treatment box 4, the treatment box cover 2 is covered, and the treatment box cover 2 is firmly adhered to the treatment box body 3 with a urethane adhesive, 502 glue.
  • a urethane adhesive, 502 glue Put the purchased nylon strap, the length of the nylon strap hanging from the neck of the human body to the height of the umbilicus, and insert it into the treatment box.
  • the treatment box 4 To treat diabetes, take out the treatment box 4 when using, pull out the suspension strap, and hang the treatment box 4 in the umbilicus of the human body, so that the bottom of the treatment box 4 has the venting hole 6 facing the umbilicus skin, and each suspension treatment is 4-5 hours. After the treatment is finished, the treatment box 4 is taken out, placed in a sealed package for recharging, and then opened again after the next use, and then placed in a sealed package for charging after use. Valid for 3 years. The invention is used for treating 84 cases of type 2 diabetes, and the effect is good.
  • 1.2 treatment method for diabetes information superconducting umbilical therapy device treatment once a day, 4 hours each time, a total of 4 weeks of treatment, before and after treatment, blood ventral blood glucose (FPG), postprandial 2h blood glucose (2hPG), glycosylated hemoglobin (GHbAl), cholesterol (Tch), triglyceride (TG) 1 time.
  • FPG blood ventral blood glucose
  • 2hPG postprandial 2h blood glucose
  • GbAl glycosylated hemoglobin
  • Tr cholesterol
  • TG triglyceride
  • test indicators before and after treatment are shown in the table 1.
  • the treatment box 4 is designed to have an oblate shape, a diameter of 10 cm, a center height of 1.5 cm, and a peripheral height of 1.2 cm.
  • the treatment box cover 2 is designed with a plurality of vent holes having a diameter of 0.1 cm, and the treatment box 4 is provided with a suspension belt and a hole 7 . It is injection molded by injection molding process ABS plastic material.
  • the information filling is packaged into the treatment box 4, the treatment box cover 2 is covered, and the treatment box cover 2 is adhered to the treatment box body 3 with a urethane adhesive, 502 glue.
  • the length of the nylon tape is inserted into the treatment box. 4 Wearing a hole 7 knotted. That is, an insomnia umbilical treatment device is prepared.
  • the treatment box 4 is hung in the umbilicus of the human body, and the treatment box cover 2 with the venting hole 6 is placed against the umbilicus skin, and is suspended for one hour before going to bed, and can be used for sleeping for one hour each time. After the treatment, The treatment box 4 is removed and stored in a sealed package.
  • the invention is used for treating 50 cases of senile insomnia, all of which are effective, and the clinical data are as follows:
  • treatment group use insomnia umbilical treatment device, hanging in the umbilicus, 1 hour before going to bed, 1 night; control group: diazepam 5mg. 0.5-1 hour before bedtime orally 1 time.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L’invention concerne un dispositif de traitement de région ombilicale humaine, qui est constitué d’une boîte de traitement (4) et d’un élément de fixation (5) associé à la boîte de traitement. La boîte de traitement comprend un couvercle (2) et un corps (3) de boîte; un médicament, sous la forme d’un bloc ou d’un sachet destiné à contenir des informations et qui est fait d’une matière d’informations non atténuées, est placé dans le corps de la boîte. Des trous d’aération sont formés sur la boîte de traitement. L’invention permet de remplacer un procédé classique de prise de médicament ou des moyens de traitement et de prévention vulnérants de maladies, des soins cosmétiques et de santé, par un nouvel apport de médicament comportant une fonction de supraconductivité d’informations, qui peut égaler ou dépasser la vitesse effective d’un traitement médicamenteux. Ce dispositif est simple à utiliser et facilite une auto-réhabilitation familiale. Aucun produit chimique ne pénètre dans le corps quand le dispositif est utilisé. Ce dispositif permet de prévenir des effets secondaires toxiques engendrés dans le corps par le médicament, ce qui permet d’économiser les ressources médicales et de réduire la pollution de l’environnement produite par l’industrie pharmaceutique.
PCT/CN2010/001090 2009-08-14 2010-07-20 Dispositif de traitement de région ombilicale WO2011017903A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200910162787.0 2009-08-14
CN 200910162787 CN101991909A (zh) 2009-08-14 2009-08-14 一种脐部治疗装置

Publications (1)

Publication Number Publication Date
WO2011017903A1 true WO2011017903A1 (fr) 2011-02-17

Family

ID=43585885

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2010/001090 WO2011017903A1 (fr) 2009-08-14 2010-07-20 Dispositif de traitement de région ombilicale

Country Status (2)

Country Link
CN (1) CN101991909A (fr)
WO (1) WO2011017903A1 (fr)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001520A1 (fr) * 1986-09-05 1988-03-10 Young Hun Suh Appareil de thermotherapie utilisant un corps en pierre ou en ceramique produisant un rayonnement dans l'ultraviolet lointain
CN1051502A (zh) * 1989-11-04 1991-05-22 华西医科大学 药物的棒状剂型及制造方法
CN2122647U (zh) * 1992-01-28 1992-11-25 代新云 一种中药热疗器
CN2182650Y (zh) * 1993-11-04 1994-11-16 杨立华 温灸理疗器
CN2501518Y (zh) * 2001-08-31 2002-07-24 李树生 理疗器
WO2005013943A1 (fr) * 2003-06-05 2005-02-17 3M Innovative Properties Company Compositions adhesives hydrophiles pour l'administration de plantes medicinales
CN101249296A (zh) * 2008-04-10 2008-08-27 宋新安 一种脐疗器
CN201469896U (zh) * 2009-08-14 2010-05-19 杨孟君 一种脐部治疗装置

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001520A1 (fr) * 1986-09-05 1988-03-10 Young Hun Suh Appareil de thermotherapie utilisant un corps en pierre ou en ceramique produisant un rayonnement dans l'ultraviolet lointain
CN1051502A (zh) * 1989-11-04 1991-05-22 华西医科大学 药物的棒状剂型及制造方法
CN2122647U (zh) * 1992-01-28 1992-11-25 代新云 一种中药热疗器
CN2182650Y (zh) * 1993-11-04 1994-11-16 杨立华 温灸理疗器
CN2501518Y (zh) * 2001-08-31 2002-07-24 李树生 理疗器
WO2005013943A1 (fr) * 2003-06-05 2005-02-17 3M Innovative Properties Company Compositions adhesives hydrophiles pour l'administration de plantes medicinales
CN101249296A (zh) * 2008-04-10 2008-08-27 宋新安 一种脐疗器
CN201469896U (zh) * 2009-08-14 2010-05-19 杨孟君 一种脐部治疗装置

Also Published As

Publication number Publication date
CN101991909A (zh) 2011-03-30

Similar Documents

Publication Publication Date Title
WO2011017903A1 (fr) Dispositif de traitement de région ombilicale
US20140291197A1 (en) Drug Suspension Agent and Method of Manufacture Thereof
CN201469896U (zh) 一种脐部治疗装置
CN101991911B (zh) 一种糖尿病超导治疗装置
CN101301350A (zh) 一种独一味提取物口服冻干片及其制备方法
CN112618147A (zh) 一种便于携带的医用陶瓷热敷袋
CN102579429A (zh) 化合物吲达帕胺在制备信息治疗药物中的用途及制备方法与所制成的新型药品
CN201727850U (zh) 一种糖尿病治疗装置
CN212817237U (zh) 一种神阙穴位敷贴
CN103417764A (zh) 含有左旋肉碱的保健品
CN211245174U (zh) 一种肛肠热奄包
CN108379237A (zh) 一种治疗泌尿道感染的药物微囊制剂及其制备方法
CN102600176A (zh) 化合物尼尔雌醇在制备信息治疗药物中的用途及制备方法与所制成的新型药品
CN102579463A (zh) 化合物格列本脲在制备信息治疗药物中的用途及制备方法与所制成的新型药品
CN206518137U (zh) 一种原生态功能食品制备装置与制备工艺
CN201759850U (zh) 一种含化给药用药袋
CN108096296B (zh) 基于菠菜萃取物的微胶囊化粉末和酸性凝胶延长产生一氧化氮的系统和用品
CN208905885U (zh) 一种多胶囊干粉给药器及多胶囊干粉给药器药盒
CN201147508Y (zh) 透皮给药制剂防渗装置
CN102600118A (zh) 化合物西布曲明在制备信息治疗药物中的用途及制备方法与所制成的新型药品
CN2320223Y (zh) 湿热敷眼罩
CN2520875Y (zh) 药物文胸
CN206063554U (zh) 自发热透皮贴
CN206045013U (zh) 一种新型脐部外用膏药贴
CN2705183Y (zh) 透皮给药贴剂

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10807848

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10807848

Country of ref document: EP

Kind code of ref document: A1